MarketingRx roundup: Myovant, Pfizer launch first Myfembree ads; IPG Health gathers medcomm agencies
Myovant Sciences and Pfizer debuted the first national TV commercial for Myfembree, their co-marketed drug approved to treat uterine fibroids.
The TV ad features a Black mom with a busy family life — a husband, two daughters, a dog, friends, exercise, work — that as she says is “not always picture perfect — plus I’m dealing with bleeding from uterine fibroids.”
Black women are 2-3 times more likely to develop uterine fibroids, more likely to get them at a younger age, and have more of them with more symptoms compared to white women, according to the Black Women’s Health Imperative. The rate of hospitalization for fibroids is three times higher for Black women than white women, the health and wellness advocacy group says.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,300+ biopharma pros reading Endpoints daily — and it's free.